| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $419.1M | +22.0% |
| Cost of Revenue | $53.5M | +34.4% |
| Gross Profit | $365.6M | +20.3% |
| R&D Expense | $80.2M | +28.6% |
| SG&A Expense | $36.7M | +2.8% |
| Operating Income | $125.1M | +10.2% |
| Pre-tax Income | $133.2M | +16.8% |
| Income Tax | $20.3M | +149.9% |
| Net Income | $112.8M |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $158.0M | +40.1% |
| Accounts Receivable | $107.0M | +32.0% |
| Current Assets | $975.5M | +7.9% |
| Total Assets | $1.14B | +14.7% |
| Current Liabilities | $139.5M | +25.4% |
| Total Liabilities | $170.8M | +51.4% |
| Stockholders' Equity | $966.1M | +10.0% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $179.6M | +41.9% |
| Capital Expenditures | $1.7M | -11.0% |
| Investing Cash Flow | -$59.9M | +90.6% |
| Financing Cash Flow | -$74.5M | -113.3% |
| Free Cash Flow | $177.9M | +42.7% |
| -27.1% |
| EPS (Basic) | $0.58 | -29.3% |
| EPS (Diluted) | $0.53 | -24.3% |